ArticleFrontiers in immunology2022

Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.

Cheng Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.